144 related articles for article (PubMed ID: 19010266)
1. New advances in high-technology radiotherapy for head and neck cancer.
Kubicek GJ; Machtay M
Hematol Oncol Clin North Am; 2008 Dec; 22(6):1165-80, viii. PubMed ID: 19010266
[TBL] [Abstract][Full Text] [Related]
2. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
[TBL] [Abstract][Full Text] [Related]
3. Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival.
Collan J; Kapanen M; Mäkitie A; Nyman H; Joensuu H; Tenhunen M; Saarilahti K
Acta Oncol; 2012 Jul; 51(6):735-42. PubMed ID: 22150115
[TBL] [Abstract][Full Text] [Related]
4. Intensity-modulated radiation therapy for head and neck cancer.
Chou WW; Puri DR; Lee NY
Expert Rev Anticancer Ther; 2005 Jun; 5(3):515-21. PubMed ID: 16001958
[TBL] [Abstract][Full Text] [Related]
5. Advances in radiotherapy for carcinoma of the head and neck.
Morris MM; Schmidt-Ullrich R; Johnson CR
Surg Oncol Clin N Am; 2000 Jul; 9(3):563-75, x. PubMed ID: 10853142
[TBL] [Abstract][Full Text] [Related]
6. Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory.
Duprez F; Madani I; Bonte K; Boterberg T; Vakaet L; Derie C; De Gersem W; De Neve W
Radiother Oncol; 2009 Dec; 93(3):563-9. PubMed ID: 19919885
[TBL] [Abstract][Full Text] [Related]
7. Reirradiation for recurrent head and neck cancer.
Patel PR; Salama JK
Expert Rev Anticancer Ther; 2012 Sep; 12(9):1177-89. PubMed ID: 23098118
[TBL] [Abstract][Full Text] [Related]
8. [Intensity-modulated radiation therapy and stereotactic body radiation therapy for head and neck tumors: evidence-based medicine].
Lapierre A; Martin F; Lapeyre M
Cancer Radiother; 2014 Oct; 18(5-6):468-72. PubMed ID: 25155467
[TBL] [Abstract][Full Text] [Related]
9. Salivary gland sparing in the treatment of head and neck cancer.
Scrimger R
Expert Rev Anticancer Ther; 2011 Sep; 11(9):1437-48. PubMed ID: 21929317
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in radiation therapy for head and neck cancer.
Bangalore M; Matthews S; Suntharalingam M
ORL J Otorhinolaryngol Relat Spec; 2007; 69(1):1-12. PubMed ID: 17085946
[TBL] [Abstract][Full Text] [Related]
11. A phase II study of primary reirradiation in squamous cell carcinoma of head and neck.
Langendijk JA; Kasperts N; Leemans CR; Doornaert P; Slotman BJ
Radiother Oncol; 2006 Mar; 78(3):306-12. PubMed ID: 16524634
[TBL] [Abstract][Full Text] [Related]
12. Strategies to Overcome Late Complications from Radiotherapy for Childhood Head and Neck Cancers.
Spiotto MT; Connell PP
Oral Maxillofac Surg Clin North Am; 2016 Feb; 28(1):115-26. PubMed ID: 26614704
[TBL] [Abstract][Full Text] [Related]
13. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
Corvò R
Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
[TBL] [Abstract][Full Text] [Related]
14. Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer.
Diaz R; Jaboin JJ; Morales-Paliza M; Koehler E; Phillips JG; Stinson S; Gilbert J; Chung CH; Murphy BA; Yarbrough WG; Murphy PB; Shyr Y; Cmelak AJ
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):468-76. PubMed ID: 19577867
[TBL] [Abstract][Full Text] [Related]
15. Accuracy requirements for head and neck intensity-modulated radiation therapy based on observed dose response of the major salivary glands.
Kapanen M; Collan J; Saarilahti K; Heikkonen J; Kairemo K; Tenhunen M
Radiother Oncol; 2009 Oct; 93(1):109-14. PubMed ID: 19435641
[TBL] [Abstract][Full Text] [Related]
16. Target coverage for head and neck cancers treated with IMRT: review of clinical experiences.
Garden AS; Morrison WH; Rosenthal DI; Chao KS; Ang KK
Semin Radiat Oncol; 2004 Apr; 14(2):103-9. PubMed ID: 15095256
[TBL] [Abstract][Full Text] [Related]
17. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer.
Bussels B; Maes A; Hermans R; Nuyts S; Weltens C; Van den Bogaert W
Radiother Oncol; 2004 Aug; 72(2):119-27. PubMed ID: 15297131
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
19. Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers.
Watkins JM; Shirai KS; Wahlquist AE; Stuart RK; Chaudhary UB; Garrett-Mayer E; Day TA; Gillespie MB; Sharma AK
Head Neck; 2009 Apr; 31(4):493-502. PubMed ID: 19156831
[TBL] [Abstract][Full Text] [Related]
20. Fractionated BNCT for locally recurrent head and neck cancer: experience from a phase I/II clinical trial at Tsing Hua Open-Pool Reactor.
Wang LW; Chen YW; Ho CY; Hsueh Liu YW; Chou FI; Liu YH; Liu HM; Peir JJ; Jiang SH; Chang CW; Liu CS; Wang SJ; Chu PY; Yen SH
Appl Radiat Isot; 2014 Jun; 88():23-7. PubMed ID: 24369888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]